![UBS raises Big 4 capex estimates](https://i-invdn-com.investing.com/news/LYNXNPEEA70L9_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.520 | 2.520 | 0.000 |
Stocks | 97.480 | 97.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.380 | 19.823 |
Price to Book | 3.659 | 4.056 |
Price to Sales | 2.173 | 2.426 |
Price to Cash Flow | 15.802 | 16.225 |
Dividend Yield | 2.070 | 1.378 |
5 Years Earnings Growth | 9.727 | 12.179 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.660 | 94.879 |
Consumer Cyclical | 1.340 | 10.020 |
Number of long holdings: 54
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.25 | 876.50 | +0.70% | |
UnitedHealth | US91324P1021 | 4.69 | 530.05 | +0.00% | |
AbbVie | US00287Y1091 | 4.67 | 192.78 | -0.10% | |
Novo Nordisk B | DK0062498333 | 3.95 | 635.1 | +0.02% | |
Merck&Co | US58933Y1055 | 3.85 | 87.70 | -0.40% | |
Thermo Fisher Scientific | US8835561023 | 3.22 | 577.48 | +0.83% | |
Pfizer | US7170811035 | 3.12 | 25.81 | -0.08% | |
Novartis | CH0012005267 | 3.03 | 97.49 | -0.23% | |
Bristol-Myers Squibb | US1101221083 | 2.97 | 57.08 | -0.59% | |
AstraZeneca | GB0009895292 | 2.84 | 11,570.0 | -1.83% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -6.06 | - | ||
FIM Emerging markets ESG | 387.8M | 4.61 | 0.29 | 4.05 | ||
S SaastOrahasto Kohtuullinen | 318.32M | 13.28 | 3.36 | 5.84 | ||
FIM USA | 302.58M | 31.21 | 10.97 | 12.22 | ||
S-Saastorahasto Rohkea | 295.17M | 17.45 | 5.20 | 8.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review